A new family of molecules that kill cancer cells and protect healthy
cells could be used to treat a number of different cancers, including
cervical, breast, ovarian and lung cancers.The researchers studied the process of DNA damage using a sort of
molecular filming technique called femto-second time-resolved laser
spectroscopy. The technique is like a high-speed camera, which uses two
pulses of light: one to start a reaction, and the other to monitor the
way the molecules react. This technique let researchers watch how
molecules interact in real-time, revealing how cells become cancerous.
This potential new field is being dubbed femtomedicine (FMD).
"We know DNA damage is the initial and crucial step in the
development of cancer," said Professor Qing-Bin Lu, lead author of the
study from the University of Waterloo, Canada. "With the FMD approach we
can go back to the very beginning to find out what causes DNA damage in
the first place, then mutation, then cancer. FMD is promising as an
efficient, economical and rational approach for discovering new drugs,
as it can save resources required to synthesize and screen a large
library of compounds."When the FMD compounds enter a cancer cell, they react strongly and form
reactive radicals, which cause the cell to kill itself. When the FMD
compounds enter a healthy cell, the cell starts to increase the amount
of a protective molecule called glutathione (GSH) in the cell. This
protects the cell against chemical toxins, so it is not damaged.
This site is for information on the various Chemo treatments and Stem Cell Therapies since 1992. This journey became bitter sweet in 2014, with the passing of my beautiful and dear wife. Sherry, had fought Non - Hodgkins Lymphoma(NHL) since 1990, in and out of remissions time and time again. From T-Cell therapies(1990's) to Dual Cord Blood Transplant(2014), she was in Clinical Trials over the years. This site is for informational purpose only and is not to promote the use of certain therapies.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment